text:
Talk:Human papillomavirus infection
|This is the talk page for discussing improvements to the Human papillomavirus infection article.
This is not a forum for general discussion of the article's subject.
Article policies
|This article is of interest to the following WikiProjects:
|It is requested that an image or photograph of the infection be included in this article to improve its quality. Please replace this template with a more specific media request template where possible.
The Free Image Search Tool may be able to locate suitable images on Flickr and other web sites.
|Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Human papillomavirus infection.
- 1 School lackage of information
- 2 Clarification
- 3 Why is this image included?
- 4 First Paragraph
- 5 External links
- 6 Prevalence 20-24 100%?
- 7 Article class and Archive
- 8 History, Origins, First recorded Occurrences?
- 9 Stealth ad link
- 10 Treatment
- 11 Drug company promotion alert
- 12 Strain 68 - "high risk" or "probably high risk"?
- 13 Cervical cancer prevention section
- 14 Current Research
- 15 Prevention - Oral sexual behaviors
- 16 Why is this viral disease chronic?
- 17 Diane Harper criticisms
- 18 Effect on infection rates of other STDs
- 19 Infection in developping world as "main reason" for cancer incidence?
- 20 Contradiction
- 21 Rearranged content in compliance with WP:MEDMOS
- 22 Co-factors in HPV-induced Cancers
- 23 HPV genome
- 24 Prevalence decreases with age
- 25 Latent viral infection - commensalism?
- 26 Vaccines
- 27 Image
- 28 Number of identified subspecies of HPV
- 29 "14% to 90% prevalence" is misused quote?
- 30 Request Updates to Diagnosis: Cervical testing
- 31 neoplasia effects
- 32 Known HPV Genome
- 33 please check my reversion
- 34 Vaccines, Paragraph 2, removed unattested statement
- 35 Reference #56 slightly derailed.
- 36 would anyone be willing to take a look at my editing?
- 37 Cancer section - unclear sentence
- 38 Outdated lead and sections
- 39 Looks like tag-bombing
- 40 What the ... ?
- 41 Treatment
- 42 Error in the HPV article
- 43 Major edit for clarity
School lackage of information[edit]
3 in 10 people have or had a form of HPV. But if one belongs to a group that changes partner more than 2 times a month and never uses condoms, then the 100% have HPV and usually 3 forms of it. Even people that are very sexually active and use condoms 8 in 10 have it, because of blowjobs or a singe time they openned the condom in a non apropriate way. Condom does not provide you a 100% safety!!! People do so many things with their hands when recorded in camera for scientific research, like touching private parts, or touching the other persons genitalia and introducing to the condom the virus before classically penetrative sex. — Preceding unsigned comment added by 22.214.171.124 (talk) 20:23, 10 June 2014 (UTC)
- Actually, if one has only one partner in their life and that person is infected, multiple partners aren't needed for them to likewise become infected. You are correct - studies have shown that many sexually active persons have HPV on their hands and under their nails. Condoms certainly won't help with that when such a person uses manual stimulation or even just minor petting on their partner. What a scourge! Thank you, Wordreader (talk) 17:20, 6 August 2014 (UTC)
Under the cancer section the following sentence is listed:
"E6 – This protein has a close relationship with a cellular protein called E6-AP (E6-Associated Protein). E6-AP is involved in the ubiquitin ligase pathway. A system which acts to degrade proteins. E6-AP binds ubiquitin to the p53 protein, thereby flagging it for proteosomal degradation."
This is indeed true for the "high risk" types of HPV, but from what I understand, the low risk versions do not activate the ubiquitin ligase pathway to degrade p53 and instead just reversibly inhibit it (leading to less mutagenic activity, hence the "low risk"). I realize that the cervical carcinomas are caused mainly by the high risk strains, but it would be helpful to note why some HPVs are not associated with malignant transformation.
Why is this image included?[edit]
It isn't referenced in the text, isn't placed in context, or explained. It is also not explained or used on another page. Not I have refrained from using a rhetorical question mark in my above interrogative title, because it isn't really adopted in common use. —Preceding unsigned comment added by Obviousmistake (talk • contribs) 03:23, 3 June 2009 (UTC)
First Paragraph[edit]
The link between cervical cancer and HPV is well reported, but mention should be made of HPV's link to anal and oral cancers - it accounts for about 70% of cases for both. —Preceding unsigned comment added by 22.214.171.124 (talk) 03:21, 22 May 2009 (UTC) Agreed - the referenced link (http://www.cdc.gov/std/hpv/stdfact-hpv.htm) now mentions potential cancers of the head and neck but the wikipedia article doesn't - this should be corrected, but I'm not familiar enough with referencing notation to do it myself. —Preceding unsigned comment added by 126.96.36.199 (talk) 23:59, 19 January 2011 (UTC)
External links[edit]
- HPV classification, life cycle, malignancy potential and more at MetaPathogen.
This external link has been repeatedly added by one contributor, and removed by others. I am moving it here for discussion. The site does not appear to meet WP:EL, specifically: WP:LINKSTOAVOID
- 1 (not a unique resource beyond what this article could be)
- 11 (personal web pages, not by recognized authority in the field) Zodon (talk) 01:14, 26 January 2009 (UTC)
- Hi Zodon, I disagree:
- 1 - topic covered in the review are far away from those that already started in the article; the article emphasizes statistics and other aspects of HPV that will be outdated rapidly, whereas the review is about viral life cycle, genome, proteins and cancer progression presented in the manner that will be true for some time and does not contradict to ANY of the reviews listed; also, if you read any review (all reviews presumed to be authorities, right?) that is listed and accessible, you will never find information about HPV that is packaged in clear and concise manner
- 11 - all websites belong to somebody; also the review is not based on personal views, NLM definitions were used whenever possible, including cancer progression stages; also, please look into appendix and find lots of citations which you can insert in this article (wher it marked "citation needed")
- I won't add this link any longer unless somebody votes for it. Thanks. XEAA —Preceding unsigned comment added by Xeaa (talk • contribs) 15:13, 27 January 2009 (UTC)
- Note that #1 says "beyond what the article would contain if it became a Featured article." This article is not up to that standard yet. Certainly this article would benefit from additional coverage of some of the areas mentioned. (If somebody wants to expand this article in those areas - great.) But as the article in the link appears to be something like a review or encyclopedia article it doesn't appear to offer anything beyond what a good encyclopedia article on the topic could offer.
- Not all reviews are presumed to be authorities/authoritative (see WP:RS and WP:MEDRS).
- 11 - The distinction is websites published by a recognized authority in a field (e.g. the CDC or Harald zur Hausen), anybody could put up a web site.
- No disparagement of the web site intended, as you observe the bibliography could be helpful here. Zodon (talk) 22:26, 27 January 2009 (UTC)
Prevalence 20-24 100%?[edit]
Is this even accurate, I find it hard to believe not to mention this can't be statistically true. Please cite the correct source! —Preceding unsigned comment added by 18.104.22.168 (talk) 05:57, 21 March 2009 (UTC)
- That was vandalism, been reverted. If see something like that it often pays to check recent revisions for vandalism. Zodon (talk) 06:48, 21 March 2009 (UTC)
Article class and Archive[edit]
After reading the article, I feel that it is extremely well-written, and if we can get sources and clear away all those fact tags, it could probably be an A-class article.
Does someone with technical know-how want to archive the old threads? It looks like we literally have years of inactive threads.--Pstanton (talk) 08:22, 29 April 2009 (UTC)
- Done. Graham Colm Talk 08:36, 29 April 2009 (UTC)
History, Origins, First recorded Occurrences?[edit]
I noticed that there isnt really a paragraph about it's history and its 'origins', when it had become prevalent. It reads like that it all came up in the past 5+ years or so, which i find hard to believe, considering the sheer volume of prevalence of different strain-types. anyone who can put some enlightenment into this ? Archangel Michael (talk) 17:25, 2 May 2009 (UTC)
- The Papillomavirus article has something on the discovery of the viruses. Skin papillomas, (benign tumours) have been a recognised lesion since the fifth century BC. The cancer link is a relatively recent discovery. Graham Colm Talk 17:37, 2 May 2009 (UTC)
- Although the association of HPV with cancer has been fairly recent, the fifth century information mentioned by User talk:GrahamColm, if verified, should be included as part of the history of this family of viruses. Information on the identification of the various types over time would be interesting, too. Does anyone have this information? As is, the "History" is a stub section. Thank you for your time, Wordreader (talk) 23:48, 30 July 2014 (UTC)
Stealth ad link[edit]
I removed a link to "hpvanswers.com", which is designed to look like a question/answer site, with a big fat link to a "homeopathic HPV remedy" on the side of the page. The timing of the posts is curious, however: the site apparently didn't exist before a couple of days ago, yet they already have a number of questions from people confused about HPV, all with well-informed answers written in perfect English, quite unlike the response style you see throughout the rest of the Internet. Further, a few refer to the "natural, homepathic" product (which apparently cures genital warts if you spray it under your tongue). The best part is that some of the responses are from the future: it's 10:35 pm EST (GMT-5) now, so at GMT+13 (the "forwardmost" time zone) it is now 4:35pm on August 4th, yet quite impressively they managed to get a number of responses from the evening of the 4th and 5th. That's one well-informed site. I wonder if they know tomorrow's lottery numbers? Anyway, keep an eye out for these sneaky snake oil pushers. – ClockworkSoul 02:42, 4 August 2009 (UTC)
"An Ob/Gyn can remove some vaginal HPV types that are viewable during a colposcopy."
This statement is not entirely true. During a colposcopy, an OB/GYN uses a high powered microscope to view the cervix. Acetic acid (vinegar) is applied to the cervix which causes abnormal cells to appear white. These abnormal cells are then biopsied. The colposcopy does not address HPV. However, the colposcopy is performed most often following an abnormal pap smear, and most cervical changes are caused by HPV. Once dysplasia is confirmed through biopsy, the appropriate treatment is prescribed. Depending on the severity of the dysplasia, the patient may undergo cryotherapy, a freezing of the cervix, or a LEEP, loop electrosurgical excision procedure. In most cases, by removing the dysplastic tissue, the HPV virus is irradicated as well. In some women, the virus is persistent. In all cases, close follow up is recommended. 188.8.131.52 (talk) 02:44, 11 August 2009 (UTC)
Drug company promotion alert[edit]
This entry has some confusing quotes about the Qiagen test that make it sound as if the test is a good thing, but that's not necessarily true.
There's no doubt that the Qiagen test is more sensitive, but the big question is whether it is clinically appropriate right now. One of the concerns is that it will lead to unnecessary biopsies, and substantial cost, without any improvement in cancer outcomes.
this gynecologist's blog is not a WP:RS, but it warns about some surprisingly heavy-handed marketing for the Qiagen test. I wonder if anyone has written anything like this in a WP:RS.
Are there any guidelines from independent organizations that clearly state whether and when the Qiagen test is appropriate? --Nbauman (talk) 02:13, 18 August 2009 (UTC)
- There's a common confusion that the difference between the pap and Qiagen's digene test is a simple matter of sensitivity, but that's not the case: while a pap smear uses direct cytological observation of cells to detect the presence of abnormal cells that may be indicative of cancer, Qiagen's assay uses molecular probes to detect HPV more directly. The problem there, however, is that while HPV is effectively a prerequisite for the development of cervical cancer, the vast majority of HPV infections will clear up without any kind of intervention. As for whether the tests are interchangeable, there is some push in that direction. While I can see some value in using this case as diagnostic of HPV infection and therefore indicating increased observation, patients (and sometimes physicians) need to understand that it's far from a prognostic indicator of cancer.
- That being said, I've been meaning to rewrite much of this article for some time... let me see what I can do. – ClockworkSoul 04:42, 18 August 2009 (UTC)
- ClockworkSoul, I got the bit about sensitivity from Runowicz's NEJM article. She understands it a lot better than we do, so read what she says and see if I paraphrased her accurately.
- There are many people who know more about DNA testing for HPV than I do, and you are welcome to revert my edits WP:BRD if you are one of them. It's a lot of work, but I'm glad you're willing to do it. (I've done a lot of medical editing IRL and one of the most difficult things to do, in my experience, is to compare and reconcile two different drafts of a manuscript, which I'm not doing now.)
- I often work on the interface of molecular biology and medicine, and I found out that they are different cultures. If you're a biologist, interesting mechanisms are very important (and I agree). If you're a doctor, the only thing that counts is whether the patient gets better at the end. Doctors respect biologists, just as aircraft pilots respect engineers. But their cultures are different.
- Doctors have a different standard of evidence. They want ideally a clinical guideline based on a meta-analysis of several consistent, large, well-designed, randomized controlled trials that demonstrate improvement in a clinically significant endpoint. For example (NEJM 361:712), it doesn't do any good if a drug lowers LDL cholesterol (a surrogate endpoint) if it also kills more people (a primary endpoint) in a randomized controlled trial.
- That's why I asked if there were any clinical guidelines.
- HPV is a surrogate endpoint. Death from cervical cancer is a primary endpoint. It's very interesting to know that a patient is infected with certain strains of HPV. The next thing a doctor wants to know is, how will this affect my management? And, how will the patient be better off at the end? A lot of doctors (for example Jeffrey Avorn) criticize the FDA for approving interventions based on surrogate endpoints rather than primary endpoints. It's not enough to prove that a drug lowers blood pressure, if you don't also prove that it reduces the primary endpoints of heart failure, kidney failure, etc.
- It's not enough to demonstrate that a DNA test will identify more HPV than a Pap test. You also have to demonstrate that using the DNA test will prevent more cervical cancer at the end of the day. The testing companies, understandably, are touting every secondary endpoint that will be improved. It's their job to advocate their test. It's the outside scientist's job to winnow back their advocacy.
- As that gynecologist says, the Qiagen page comes up with a meaningless "secondary outcome" of "reassuring" women. As she says, it's more likely to create greater anxiety. Qiagen lists all kinds of secondary outcomes that are clinically irrelevant. This is a confusing collection of technical jargon that a normal person can't possibly understand. Yes, they cite peer-reviewed sources. If you examine that Qiagen page carefully, you'll see that they are using a NEJM article which says that DNA testing would be acceptable in limited resource countries (if they can get a cheaper test instead). That seems to be deceptive.
- To quote secondary outcomes is deceptive. To say that the FDA approved the Qiagen test as the "primary screening tool for detecting HPV" is wrong, as I understand it. I can't find it in any of the sources. Where does a source say that the FDA approved Qiagen as a primary screening tool? (I can't find the approval letter on the FDA's web site.)
- There's a link to a NEJM article by Mayrand. But that article was also published with an editorial by Runowicz which gave WP:NPOV reasons about the limitations of the Qiagen test. It is Wikipedia policy WP:MOS WP:MEDMOS to use secondary sources rather than just primary research, since secondary sources can evaluate the resarch. I don't understand why you removed my reference to Runowicz.
- You can go ahead and edit this. But I checked the sources to make sure they supported the claims, and I expect you to do the same. This is a potentially useful test. The literature says it would be useful in resource-poor environments if the price can come down. The literature says it would be useful in the U.S. and European countries if it can meet our standards of evidence-based medicine (which is not the same as regulatory approval.) If somebody is looking to Wikipedia for help in evaluating that Qiagen promotion, that's what this page should say.
- ClockworkSoul,, here it is from your own link: HPV DNA Test - English (PDF)]:
- "The hc2 HPV DNA Test is not intended for use as a screening device in the general population."
- The article as it stands now is wrong. The hc2 [sic] HPV DNA test is not a "primary screening tool." Nor do I see any source that says it's a gold standard.
- Here's the FDA approval notice: Digene Hybrid Capture 2 High-Risk HPV DNA Test - P890064 S009 A004 "The HPV-DNA Test is used only in conjunction with Pap Testing." This is absolutely not a primary screening tool. --Nbauman (talk) 21:49, 18 August 2009 (UTC)
Strain 68 - "high risk" or "probably high risk"?[edit]
The chart in the "HPV types and associated diseases" section lists strain 68 as "probably high risk" but the text above the chart lists it as "high risk." Which is correct? If debatable, the text and chart should at least be made consistent one way or the other... IMKatgrrl (talk) 19:55, 21 August 2009 (UTC)
Cervical cancer prevention section[edit]
A recent edit [1] changed the name of the section "Cervical cancer prevention" to "HPV prevention". Although the article is about HPV, the section in question is about prevention of cervical cancer, not HPV. Pap smears, HPV testing and smoking avoidance all apply to prevention of cervical cancer, and for the most part do not prevent HPV infection. Condom use operates in two fashions - it can protect against transmission of HPV, but it also is protective against cervical cancer, even if HPV or dysplasia already present (possibly by reducing exposure to immune suppressive agents in semen).
So the title HPV prevention does not make sense for the section. Zodon (talk) 05:32, 8 September 2009 (UTC)
- The article is about HPV so it deserves a prevention section, cervical cancer is not HPV, further prevention of associated diseases should be discussed in their own article and early diagnosis in the appropriate section.--Nutriveg (talk) 17:00, 8 September 2009 (UTC)
- While most of the coverage of diseases should be in article on the disease, it is usual to cover the diseases that a pathogen causes in the article on the pathogen. (The diseases are the main reason people are interested in HPV.) See, for instance HIV.
- While the coverage of most of the diseases here is confined to the section specifically on that disease, Cervical cancer is the most significant disease associated with HPV, so it has received more attention - both in terms of medical interventions, and in coverage here. (I believe the article used to say something about prevention or treatment being covered under individual disease sections.)
- Until recently (with development of HPV vaccine), most of the prevention techniques have dealt with specific diseases, rather than with preventing infection by the virus. (I am not saying the current arrangement is wonderful, just observing how it has evolved and why it makes some sense.)
- I am not sure how it would work to have a section specifically on HPV prevention -
- presumably prevention section would contain the sections on HPV vaccine, contact with shared objects, and microbicides.
- Pap smears and HPV testing clearly warrant coverage in this article, but don't make sense in an HPV prevention section. Presumably they would remain under Cervical cancer prevention.
- Some sections are unclear where they would go. The condom section becomes a bit dicey, since there are at least two possible mechanisms there, and it may not be clear whether one or the other or both are responsible for the effects. (Is it reduced exposure to HPV, reduced exposure to immune-suppressive components of semen, both, ...?) Smoking avoidance - again not so clear, I don't know the mechanism, whether applies to HPV prevention or just to developing cancer, or both.
- Having an HPV prevention section would put the HPV vaccines section in a clearer place, since some vaccines protect against genital warts as well as cervical cancer.
- However would also need to consider what information about protection from warts would be apropos of such a section. Since protecting against several different diseases, methods for protecting against some might be irrelevant to others.
- It isn't clear how to split things up to make an HPV prevention section, as compared to the current arrangement of covering prevention by disease. Could you suggest how to handle some of the difficulties with making an HPV prevention section. Zodon (talk) 19:41, 8 September 2009 (UTC)
- Even HIV being the directly causes of a single disease I don't see the same problem in that article. If it's specific about Cervical Cancer it belongs mainly to that article which section should be shortly referenced here. HPV vaccines are about HPV types, not diseases, since some types are associated with various diseases.
- Pap smears and HPV testing belong to detection. Details could be added to contamination of specific parts of the body, and factors increasing contamination (cuts, sperm, ...). Smoking doesn't belong here and vaccines are about HPV types which can cause one or more diseases. I don't see much problem at all and feel that you're just delaying change by making too much noise for a simple change in the section title.--Nutriveg (talk) 21:12, 8 September 2009 (UTC)
- I am not sure how it would work to have a section specifically on HPV prevention -
- Why doesn't smoking belong here?
- So how do you deal with condoms, where the mechanism is unknown, and may be multiple?
- As already pointed out, just changing the section title would make it incorrect. There is no a-priori reason that can't have a section titled as it currently is in this article. Since I see some merit in the general approach suggested, I am trying to see how to make it work. Zodon (talk) 06:24, 9 September 2009 (UTC)
(Outdent) I came up with an alternative title (Disease prevention) that might address your concern. If there is wikipedia policy that indicates what sections titles may or may not be in an article, or why a section title must fit the article title, or what the criteria are for such fit, please indicate where/what the policy is. Zodon (talk) 17:36, 9 September 2009 (UTC)
- As noted above, most of the material in the section does not deal with infection prevention. Infection seemed implicit in the "HPV prevention" title (since preventing HPV in general is not an option).
- I think that the disease prevention title is clearer than just prevention, since probably the reader would infer that Prevention means HPV infection prevention. (Just as treatment would be inferred to be "treatment of HPV infection".) So clearer to indicate the more general coverage of preventing diseases (implicitly those caused by HPV), rather than the more limited preventing infection.
- Suggest we leave it at disease prevention for now. Zodon (talk) 20:33, 10 September 2009 (UTC)
Current Research[edit]
I removed the following section today:
- A 2009 study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, suggests that having the human papillomavirus (HPV) improves survival in Squamous cell carcinoma of the head and neck. Furthermore, African Americans had far less HPV infection than whites, which led to worse survival.[1]
This seemed a little hinky to me, so I read the cited source and found that its conclusion is very different from what's written above. What the authors did write was interesting, but not earth-shattering: as a group, head and neck tumors in blacks had less HPV than those in whites, and were also more resistant to treatment. Also, the authors presented data that showed that head and neck cancer caused by HPV is considerably more responsive to chemotherapy than cancer that arises spontaneously. The authors didn't speculate on the reason for this relationship, or for the reasons behind the differences in HPV status in the head and neck tumors of the two ethnic groups. To say that the study suggests that "having the human papillomavirus improves survival", however, is way off. – ClockworkSoul 12:41, 10 September 2009 (UTC)
- I thought the item looked suspicious, but hadn't gotten around to checking it. Thanks.
- I restored the current research section title, since the Microbicides subsection was also in that section. Zodon (talk) 18:48, 10 September 2009 (UTC)
I'm thinking of adding some more specific, but brief, summaries of academic research in a couple of areas where it's missing: hand transmission, clearance, and testing. I'm thinking Clearance can go at the end of Virology, but am open to other ideas. Numbersinstitute (talk) 23:59, 23 August 2012 (UTC)
Prevention - Oral sexual behaviors[edit]
- Odds of oral HPV infection increases with increases in the number of recent oral sex partners or open-mouthed kissing partners.[1]
The sentence above added to the disease prevention section, under the title Oral sexual behaviors. So far it appears to just indicate a possible risk factor, not a recommended prevention. It seems okay as a risk factor in the head and neck cancer coverage (I moved it there, but it was moved back), or could be reworked to include coverage of recommended prevention and put back in prevention section. But doesn't make sense to have in prevention section when it doesn't document a widely recognized prevention strategy. Zodon (talk) 19:36, 17 September 2009 (UTC)
- Prevention is about preventing from risk factors (in this case increased number of partners). The cited research is about HPV infection, not about specific types, not about head and neck cancer. HPV can cause other (or no) diseases and cross contamination is possible. Please don't make original research.--Nutriveg (talk) 20:23, 17 September 2009 (UTC)
- The study is about oral HPV infection, which is one of the causes of orophyrengeal cancer (a subset of head and neck cancers). So it is related to head and neck cancer - just a different name.
- Since they did not study transmission from oral to other sites, it has no clear relation to other diseases. (Various studies have indicated routes of acquiring oral infection, but what studies indicate transmission from oral to other sites, e.g. oral to genital?)
- The text in question says nothing about prevention. The section is about prevention of disease. A risk factor is not the same as a preventive measure. Sometimes there is nothing that can be done about a risk factor. Sometimes the prevention would be worse than the disease, or so costly, unpleasent, etc. that people would not do it. The article says so little about prevention it is difficult to see what it could support by way of prevention. If you think it belongs in prevention - what preventive measure do you think the article or the text you are proposing suggest?
- The study has several limitations. The study notes that the results can not be applied to the general population (so the statement above is over-general).
- Since you were proposing the addition, no idea what you mean by original research by others.
- As far as original research, the only prevention method that I found mention of in the article is the timing of HPV immunization, and the article says nothing specific about that. So putting this in a new section in prevention certainly qualifies as original research as far as this reference goes, as would asserting this transmission mode links to diseases other than orophyrengeal/head and neck cancer. Zodon (talk) 07:06, 18 September 2009 (UTC)
- Exactly, it's about oral HPV infection and you first tried to make that study particular about "oral cancer" and now about "oropharyngeal cancer", later you'll say it's about "oral warts". This is original research! We should cite study results exactly as it was done by their authors, and that was merely what I did, I only failed to mention "Among college-aged men" which should be added instead of deleting the rest. Even considering study limitations the authors didn't change their conclusion: "Oral sex and open-mouthed kissing are associated with the development of oral HPV infection."
- That article conclusions were additionally cited by other articles: "HPV infection in the oral cavity and pharynx has been linked to the lifetime number of oral sex partners and number of openmouth kissing partners", "infection were associated with recent number of oral sexual partners, including number of oral sexual partners and number of oral-to-oral (kissing) partners". You are just changing excuses to remove content you don't like. The text belongs to the HPV article as a whole, not to a specific disease.--Nutriveg (talk) 08:26, 18 September 2009 (UTC)
- The first sentence of the article says "Oral human papillomavirus (HPV) infection is a cause of oropharyngeal cancer." So, since the same article that has the result in question also says it is (causally) related to oropharyngeal cancer, in what way is saying that this result is related to oropharyngeal cancer original research?
- My first response (as you just noted) was to move the content. Now you claim I am trying to remove it with any excuse???
- You still haven't addressed the main point - you are asserting that this is prevention of HPV infection or disease. Where in the article does it say that, and what about this is prevention? Zodon (talk) 22:19, 18 September 2009 (UTC)
- The phrase you cited is the article motivation. The article conclusion talks about HPV infection, it doesn't restrict its results to specific diseases or HPV types associated with particular diseases, you created that restriction yourself, that's original research.
- First, you tried to remove it to the cancer section, more specifically to "next to rest dealing with oral ca(ncer)". Later, when risk factors were mentioned, you changed your excuse to "risk factors don't belonging to the prevention section", ignoring the condom section just above. Later you criticize the study quality. And now you demand the article itself to say which article section it should be included, where no wikipedia policy or guideline impose that restriction. As I said and repeat: "You are just changing excuses"
- My point is that "text belongs to the HPV article as a whole, not to a specific disease", the more appropriate place to preventable risk factors, in this article (as by the condom example) and most Wikipedia medical articles is the prevention section, while the established causes stay in the causes section. See the Manual of style and the example of a featured article.
- If you didn't notice so far, I'm just citing the authors conclusions, which talk about "HPV infection" not disease.--Nutriveg (talk) 01:29, 19 September 2009 (UTC)
- We are not limited to citing what is in the conclusions section of the article. The prohibition is against original synthesys. If the article said nothing about oral cancers and just talked about HPV transmission, then one might be able to argue that linking the articles findings to oral cancers was original synthesys. However since they make the connection, then us using that connection is not original research in the wikipedia sense. Zodon (talk) 09:56, 24 September 2009 (UTC)
- ^ D'Souza, G.; Agrawal, Y.; Halpern, J.; Bodison, S.; Gillison, M. (May 2009). "Oral sexual behaviors associated with prevalent oral human papillomavirus infection" (PDF). The Journal of infectious diseases. 199 (9): 1263–1269. doi:10.1086/597755. ISSN 0022-1899. PMID 19320589.
It would be informative to include some description as to the mechanisms used by this virus to avoid the body's immune responses. Currently in this article the only piece of information mentioning the clearing of this virus from the body is a single line from WebMD: http://www.webmd.com/sexual-conditions/hpv-genital-warts/hpv-treatment-is-there-hpv-cure. This source doesn't provide any other details about this process.
From the virus Wikipedia entry, "Viral infections in animals provoke an immune response that usually eliminates the infecting virus." On that page it also states, "However, some viruses including HIV and those causing viral hepatitis evade these immune responses and cause chronic infections." On both the HIV and the viral hepatitis pages, there are descriptions of the known mechanisms each specific chronic virus uses to avoid clearing after the initial immune response. Is this information missing from the HPV entry because the specific mechanism isn't yet known? —Preceding unsigned comment added by 184.108.40.206 (talk) 01:24, 16 October 2009 (UTC)
- In short, yes, little is known about exactly how HPV manages establish persistent infections in some individuals while being effectively cleared by most others. One major reasons for this is that HPVs are notoriously difficult to culture in the lab, and no good animal models exist (there are, however, a handful of mediocre ones). It's been appreciated for a few years, though, that these viruses are, to quote this pretty good review article , "experts at avoiding or subverting the host immune response". I'm trying to find some time to rewrite this article; I'll include what I can find on this subject when I do. – ClockworkSoul 00:22, 11 January 2010 (UTC)
- Thanks!--220.127.116.11 (talk) 01:36, 23 January 2010 (UTC)
- The article that Clockwork provided a link for is "Immune evasion in human papillomavirus-associated cervical cancer" from the journal, Nature Reviews Cancer. The following quote is from the University of California at San Francisco's Dysplasia Clinic informational website, "Anal Cancer Info", a collaboration between the UCSF Dysplasia Clinic and the American Cancer Society. It underscores that even now, twelve years after that article, still little is known about the natural history of HPV in humans and it's resulting cancers:
- "What is the natural history of anal HPV infection? We don't really know since long-term studies have never been done. What is clear though is that most people don't run into trouble from HPV infection. Some people develop AIN [anal intraepithelial neoplasia] due to HPV infection, but most of the cases of AIN will not progress to cancer. In most people the AIN will go away by itself and they will not even have been aware of it. But for some people can be a real problem."
- Last paragraph on the page, http://id.medicine.ucsf.edu/analcancerinfo/hpv/ Thank you, Wordreader (talk) 06:29, 19 November 2014 (UTC)
- I found the abstract of an article that mentions HPV's ability to evade the immune system and the mechanism whereby the infection eventually leads to cancer. I don't know enough cellular biology to know if this info differs materially from what appears in this article. If you are interested, it might be possible to get the full article through the medical library at your nearest hospital or a medical center. See: "Human papillomavirus-related diseases of the female lower genital tract: oncogenic aspects and molecular interaction", journal Collegium Antropologicum (appears to be in English, at least the abstract is), 2014 Jun;38(2):779-86.
- "The immune system uses innate and adaptive immunity to recognize and combat foreign agents that invade the body, but these methods are sometimes ineffective against human papillomavirus. HPV has several mechanisms for avoiding the immune system." I would hope that the full article expands on this idea. Meanwhile, "Approximately 10% of individuals develop a persistent infection, and it is this cohort who is at risk of cancer progression, with the development of high-grade precursor lesions and eventually invasive carcinoma." Yikes! I thought it was a lower percentage. Thank you, Wordreader (talk) 08:04, 19 November 2014 (UTC)
Diane Harper criticisms[edit]
There seems to be some contention about the recent addition regarding Diane Harper's criticisms on the vaccine: whether Harper is a reliable source, and if so, whether the content is a reliable paraphrase of her view. I'd like to open discussion here so others may add their views. This could also effect the information added on the article Gardasil as well. Auntie E. (talk) 03:33, 12 January 2010 (UTC)
- That was not a recent addition, user "SuaveArt" used a deceptive edit summary, saying he was removing spam, to remove that content so I didn't realize that until now. That is valid content. User "SuaveArt" is the one proposing changes, probably stalking user "Seregain" edits, since "SuaveArt" is not an active editor in this topic. That said "Seregain" edit looked a little bit biased but I balanced it.--Nutriveg (talk) 10:46, 12 January 2010 (UTC)
- I removed the section again, since it's more than just a bit biased, and all the link to the more reliable source does is tell us more reliably that she said it (but it does nothing to tell us whether it's likely to be true). Since there's really no actual data to support her assertions, and Harper's a reasonably well-known anti-vaxx "expert", a using the quote as a source amounts to nothing more than an argument based entirely on an argument from (questionable) authority. – ClockworkSoul 03:26, 13 January 2010 (UTC) (Copyedited for clarity – ClockworkSoul 16:54, 13 January 2010 (UTC))
- She is a recognized authority in the subject, he was hired by the two companies that make the vaccines and her studies were cited by other scientists. I'll rewrite that later.--Nutriveg (talk) 11:35, 13 January 2010 (UTC)
- The growing scientific consensus is that human papillomavirus was created in a lab, during research on the origins of certain marine isopod diseases. The original intentions were good but it was later released in to the human population in order to sell the vaccine. —Preceding unsigned comment added by 22.214.171.124 (talk) 14:19, 28 March 2010 (UTC)
- I removed the section again, since it's more than just a bit biased, and all the link to the more reliable source does is tell us more reliably that she said it (but it does nothing to tell us whether it's likely to be true). Since there's really no actual data to support her assertions, and Harper's a reasonably well-known anti-vaxx "expert", a using the quote as a source amounts to nothing more than an argument based entirely on an argument from (questionable) authority. – ClockworkSoul 03:26, 13 January 2010 (UTC) (Copyedited for clarity – ClockworkSoul 16:54, 13 January 2010 (UTC))
- I don't think her statements can really be called "criticisms" as she never advised against people using the vaccine. Just an observation. In any case, Harper was the lead researcher for the HPV vaccine, so I don't see how she could not be seen as a reliable source. If I have misread the reports of her statements, please correct and accept my apology. Seregain (talk) 14:41, 13 January 2010 (UTC)
- My major gripe with the addition isn't so much the statement itself as the complete lack of context and perspective. In fact, I wouldn't be surprised if the HPV vaccine doesn't reduce the rates of cervical cancer among women who get annual pap smears. It's important to remember a number of points, however. First, there is a significant percentage of the population that either has limited access to health care, or (which always boggles my mind) simply chooses not to use it when it is available. Second, the vaccine certainly will reduce the number of pre-cancerous neoplasms, and therefore the often very unpleasant unpleasant procedures that are used to interrupt the progression of high-grade lesions to full-blown cancer. Finally, we shouldn't forget that the vaccine also targets types 6 and 11, two agents of genital warts that have no currently measurable association to cancer. – ClockworkSoul 16:49, 13 January 2010 (UTC)
- Well for me she criticizes the importance given to the vaccination compared with screening, the administration of the vaccine for children under 15, the lack of information of the duration of vaccine efficacy, the importance of continued screening, ... All we can rewrite of course, but I don't agree to represent "criticism of her opinion" that can't be equally sourced.--Nutriveg (talk) 19:01, 13 January 2010 (UTC)
- Which is essentially what she's saying in the originally quoted source... however, this article doesn't read that way in its current form. One could forgive a nervous reader, confused and perhaps frightened by the bombardment of misinformation from all quarters, interpreting it as meaning that the vaccine won't reduce cancer and therefore isn't worth getting. I'm actually thinking that the comment really shouldn't be in the human papillomavirus article in the first place, since she's really discussing the vaccine, and not the virus, and while an overview of the vaccine topic is appropriate, a full examination of the issues is beyond this article's scope. So I'm actually suggesting two things: we first move the Harper stuff to HPV vaccine, and then we deal with the content as reasonably as possible over there. – ClockworkSoul 21:50, 13 January 2010 (UTC)
- Sorry, my interest is restricted to HPV article, not "HPV vaccine", so I expect to discuss those issues in the context of this article.--Nutriveg (talk) 23:46, 13 January 2010 (UTC)
- That's a curious response... Generally, when deciding the contents of articles, the personal interests of the editors matter less than the relevance of the material to the subject of the article. I'm not at all convinced that Dr. Harper's assertions are relevant enough to the human papillomavirus subject to be included in what should be a brief summary of the HPV vaccine article, especially when it's not even discussed to any degree in the HPV vaccine article itself. – ClockworkSoul 00:23, 14 January 2010 (UTC)
- Sorry, my interest is restricted to HPV article, not "HPV vaccine", so I expect to discuss those issues in the context of this article.--Nutriveg (talk) 23:46, 13 January 2010 (UTC)
- Which is essentially what she's saying in the originally quoted source... however, this article doesn't read that way in its current form. One could forgive a nervous reader, confused and perhaps frightened by the bombardment of misinformation from all quarters, interpreting it as meaning that the vaccine won't reduce cancer and therefore isn't worth getting. I'm actually thinking that the comment really shouldn't be in the human papillomavirus article in the first place, since she's really discussing the vaccine, and not the virus, and while an overview of the vaccine topic is appropriate, a full examination of the issues is beyond this article's scope. So I'm actually suggesting two things: we first move the Harper stuff to HPV vaccine, and then we deal with the content as reasonably as possible over there. – ClockworkSoul 21:50, 13 January 2010 (UTC)
- Well for me she criticizes the importance given to the vaccination compared with screening, the administration of the vaccine for children under 15, the lack of information of the duration of vaccine efficacy, the importance of continued screening, ... All we can rewrite of course, but I don't agree to represent "criticism of her opinion" that can't be equally sourced.--Nutriveg (talk) 19:01, 13 January 2010 (UTC)
- My major gripe with the addition isn't so much the statement itself as the complete lack of context and perspective. In fact, I wouldn't be surprised if the HPV vaccine doesn't reduce the rates of cervical cancer among women who get annual pap smears. It's important to remember a number of points, however. First, there is a significant percentage of the population that either has limited access to health care, or (which always boggles my mind) simply chooses not to use it when it is available. Second, the vaccine certainly will reduce the number of pre-cancerous neoplasms, and therefore the often very unpleasant unpleasant procedures that are used to interrupt the progression of high-grade lesions to full-blown cancer. Finally, we shouldn't forget that the vaccine also targets types 6 and 11, two agents of genital warts that have no currently measurable association to cancer. – ClockworkSoul 16:49, 13 January 2010 (UTC)
- I deserve the right to decide which articles I want to edit, the HPV vaccine article is a mess I don't want to get further involved. The original source has been superseded by a secondary source by the same author, which balances pretty well the benefits listed in that section.--Nutriveg (talk) 00:45, 14 January 2010 (UTC)
- I'm happy with your recent edits. Well done. – ClockworkSoul 03:48, 14 January 2010 (UTC)
- Hi, just for the record, there was never any consensus to add the paragraph to begin with (it was added by Seregain, then removed and re-inserted a few times). Also please note that Seregain is an evangelical Christian and has made it obvious by several of his edits that he added this here in order to push an abstinence-only POV (which is why I searched his edits after detecting hints of bias on his part).--SuaveArt (talk) 00:22, 17 January 2010 (UTC)
- I'm happy with your recent edits. Well done. – ClockworkSoul 03:48, 14 January 2010 (UTC)
Effect on infection rates of other STDs[edit]
HPV infections affect susceptibility to other STDs - in most causes elevating risk but paradoxically also preventing seroconversion of AIDS under specific circumstances. In the long term such indirect effects could become one of the most important points in evaluation of HPV vaccines, yet it is hard to predict at the moment. Did anyone have a look into this? Richiez (talk) 09:18, 27 July 2010 (UTC)
Infection in developping world as "main reason" for cancer incidence?[edit]
I do strongly disagree with this edit. The previous version imho represents mainstream opinion. Did you check that the source really claims what the edit says? Even if it does, it is not a review and should not be used to push such controversial content. Richiez (talk) 13:47, 27 September 2010 (UTC)
- Hi Richiez. I think you misread my edit. Higher infection is the main cause for higher cervical cancer, Parkin says, and it makes sense, doesn't it? The cited source (Parkin, freely available via PubMed) compiles different sources, so although it is not a review, it is kind of a review. The 3rd sentence of the discussion reads
- The percentage of infection-attributable cancer is higher in developing countries (26.3%) than in developed countries (7.7%), reflecting the higher prevalence of infection with the major causative agents (hepatitis viruses, HPV, HP and HIV) (Table XI).
- I originally only wanted to delete the first part of the sentence related to the causal relationship between less Pap smears and higher cancer incidence, because this is not even mentioned in the cited source, but since I found in the same source the cited explanation claiming a causal relationship between infection and infection-attributable cancer incidence, I added this. If you feel that Parkin's claim is not backed up enough, we can agree to leave it out, but please also leave out the totally unsourced part about Pap smears.--Biologos (talk) 16:12, 27 September 2010 (UTC)
- I deleted the Pap smear part and left the disputed part out, too. Now the rest seemed to fit better in the Epidemiology section, so I moved it. I hope we can agree on this.--Biologos (talk) 16:25, 27 September 2010 (UTC)
- I agree with Richiez
- Parkin's claim is dubious at best with relation to HPV. He provides no source to back up that claim. The most charitable interpretation I can figure is that the other factors are more prevalent in less developed countries (though there may be more to it for even those - since antiretrovirals, etc., are also less available in less developed countries). For HPV I have seen no evidence that it is less prevalent in developed countries, and there is no reason to expect that at this time. Higher infection with HPV could conceivably be a cause, but greater availability of preventive treatments (which come after HPV infection, but before cervical cancer) is a much more likely explanation.
- The efficacy of Pap smear screening programs is well established. Such programs have resulted in an approximately 80% decrease in cervical cancers. (cite journal| journal = Annals of Oncology | volume = 21 | page = 448–458 | year = 2010| title = European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition | author = M. Arbyn; et al. | number = 3 | doi=doi:10.1093/annonc/mdp471 ) The decrease in cervical cancer in the US and many developed nations in recent decades has been attributed to Pap smear screening. Such programs are much less common in developed nations. The effect of Pap smear screening on cervical cancers is sufficiently large that it would explain most of the (approximately 80%) difference in cancer prevalence between more and less developed nations.
- So a citation would improve that claim, but it does reflect the mainstream opinion.
- When I added the Parkin citation (to a sentence that had no citation at all), it was as a citation for the relative prevalence, not for the reason. I tried to clarify that by putting in a citation needed tag for the first part.
- As far as the claim that HR HPV is significantly more prevalent in less developed nations, would need much better sources to back up that Parkin's claim applies to HPV and that it is a widely held opinion. Zodon (talk) 19:20, 27 September 2010 (UTC)
- From just reading the abstract, the de Sanjose reference also seems a bit dubious as support for the claim. It does not appear to differentiate based on development status, (for instance, Asia - which has a large proportion of developing nations has the lowest incidence in their summary). Also, it isn't clear that they adjust the data for other factors like age (HPV infection strongly correlated with age, and development status also has correlations with age distribution). Zodon (talk) 19:49, 27 September 2010 (UTC)
- Hi Biologos, I did not misread your statement. Regarding the sentence you quote look at the definition of attributable that the author uses. Simply put he says 100% of cervical cancers are attributable to HPV. This is true or "good enough for all practical purposes" but he does not say that it is the only cause and nowhere does he say there are no other causes - you seem to have overinterpreted the statement. To explain it a bit drastically HPV may cause cervical carcinoma but if you amputate the cervix you are pretty safe from getting it. So you can at the same time claim that (a) 100% of cervical cancers are attributable to HPV and (b) 100% are attributable to not having an amputated cervix and (c) 100% are attributable to beeing a women. Richiez (talk) 20:59, 27 September 2010 (UTC)
- Thanks to both of you for your comments. I see what you mean. Parkin's opinion is not backed up by data in the cited paper, so it's best to leave it out. Since the beneficial effect of Pap smears is already mentioned two paragraphs above*, my changes to the sentence and the move still seem the right thing to do. Agreed? *Zodon, if you apply the same high standards of scientific evidence you applied to Parkin's claim to the claim that "Pap smears have reduced the incidence and fatalities of cervical cancer", we'll need much better sources than the home page of the NCCC. According to Pap test and the discussion there, an increase in Pap smears correlates with a decrease in cervical cancer, but the relative importance of Pap smears for this is hard to quantify.--Biologos (talk) 08:00, 28 September 2010 (UTC)
- The sentence is fine as it is now. The data in Parkin's paper appears sensible though highly specialised. The problem was that the earlier edit was a subtle bit of WP:SYNTH over data that is not easy to interpret. Parkin did write about infections and cancer and choose not to deal with pap smears at all which is fine but that also means that this data can not be used to establish the relative relevance of pap smears and infection prevalence. As a rule of thumb when dealing with research papers - data or claims that are not mentioned in the abstract are most often not suitable for wikipedia. As of "pap smears have reduced the incidence and fatalities of cervical cancer" it would be easy to find sources to back this statement (PMID 17296477), it is much more difficult to find sources that give an overview about how large this effect may be realistically (eg PMID 8747379)Richiez (talk) 20:18, 28 September 2010 (UTC)
- Biologos - Removing it was okay by me. It was peripheral since this article is about HPV, rather than cervical CA or Pap smear. (And, as you note similar observation about efficacy of Paps already covered.) Moving it down into the body was okay too.
- Not sure what you are saying about sourcing for the Pap smear reducing cervical cancer incidence. The NCCC reference seems okay (although as far as I can see it is mostly a reference for the statistics on deaths). It may not be the highest quality reference, but it isn't being used to back up some extraordinary claim. The observation that Pap smears reduce cervical cancer is a commonplace - sure, a citation is worthwhile for the sake of completeness and style (e.g. to eventually get article to a better quality grade), but there is nothing controversial or unexpected about that claim. (Extraordinary claims require extraordinarily good sources (therefore looked very closely at Parkin - since what was said was extraordinary), conversely pedestrian claims don't require as good sources. Not saying that good sources aren't better - just don't have to be so careful about undue weight, etc.)
- The Arbyn reference above substantiates the claim that Pap smears have reduced cervical cancers; since Arbyn is, among other things, a review citing other sources it is a reasonably good source. It also gives an idea of what a comprehensive screening program can reasonably achieve (80% reduction in cervical CA). (I would not suggest using PMID 8747379 - some of the claims they make in the abstract are dubious at best, also it would be less preferred since it is a non-english source. There are lots of more accessible sources.) Zodon (talk) 05:01, 29 September 2010 (UTC)
In section "Cancers": Sexually-transmitted HPVs also cause [...] approximately 25% of cancers of the mouth and upper throat (the oropharynx) (see figure). But the figure "HPV-induced cancers" shows a much smaller fraction of both mouth and throat cancers as HPV-induced. The cited source for both the number and the graph (Parkin 2006) says on p.3033 after discussing the evidence: For the purpose of estimation, it is assumed that 3% of oral cavity cancers and 12% of cancers of the oropharynx are attributable to HPV. That can hardly add up to 25%.--18.104.22.168 (talk) 01:38, 20 February 2011 (UTC)
Rearranged content in compliance with WP:MEDMOS[edit]
This is similar to the format we see at HIV. --Doc James (talk · contribs · email) 06:28, 1 March 2011 (UTC)
Co-factors in HPV-induced Cancers[edit]
In the Genital HPVs section there's a note that "epidemiological and molecular data suggest that co-factors such as the cigarette smoke carcinogen benzo[a]pyrene (BaP) enhance development of certain HPV-induced cancers." I realize that it's a narrow point, but BaP is present in many more human activities than just cigarette smoking, including eating barbecued meats. Do we want to broaden this statement? 18.104.22.168 (talk) 15:30, 13 May 2011 (UTC)
i want to know if woman with cervical cancer can have sex and if hpv originated from male and transfered to woman? — Preceding unsigned comment added by 126.96.36.199 (talk) 03:15, 30 May 2011 (UTC)
HPV genome[edit]
Had to fix a few mistakes in the E6/E7 proteins section. The genome is stated to be composed of 'proteins' instead of genes; E3 was mistakenly listed as an HPV gene; E5 gene and long control region were absent. Casonthemason (talk) 17:41, 23 February 2012 (UTC)
Prevalence decreases with age[edit]
The following was recently deleted from the article.[2]
Note that prevalence decreases with age. This may be due to the HPV infections being cleared by the immune system, or sinking to undetectable levels while still present in the body.[citation needed]
The summary alleged that it was untrue. Which portion do you doubt? That prevalence decreases, or that it is unknown about clearance. The former is of course true. The latter has been true, though if you have citations that support it is now known one way or other I would be quite interested. Parking here to gather citations for reinstatement. Zodon (talk) 07:05, 4 May 2012 (UTC)
Hi, I think that the comparison of certain HPVs with shark suckerfish that was added in 2006 (http://en.wikipedia.org/w/index.php?title=Human_papillomavirus&diff=prev&oldid=58110537 ) and recently deleted (http://en.wikipedia.org/w/index.php?title=Human_papillomavirus&diff=491287539&oldid=491137361 ) and subsequently restored is not very good. Latent viruses don't eat, do they? Also, HPV-5, mentioned as harmless in the sentence before, can also cause warts, see http://www.stanford.edu/group/virus/pox/2000/HPV5.html .--Biologos (talk) 11:04, 8 May 2012 (UTC)
This section reads: "HPV vaccines (Cervarix and Gardasil), which prevent infection with the HPV types (16 and 18) that cause 70% of cervical cancer, may lead to further decreases." Do the vaccines cause cervical cancer or do HPV type 16 and 18 cause cervical cancer? Aleksandar Bulovic' (talk) 17:52, 10 July 2012 (UTC)
- HPV causes cervical cancers. HPV vaccines prevent HPV infections. Do you think it's unclear, because if it is, we should rewrite?SkepticalRaptor (talk) 22:40, 10 July 2012 (UTC)
- I do feel that way, yes. Maybe: "HPV vaccines, Cervarix and Gardasil, which prevent infection with the HPV types 16 and 18(Which are responsible for 70% of cervical cancer), may lead to further decreases." Aleksandar Bulovic' (talk) 20:54, 11 July 2012 (UTC)
The FDA has recently approved Gardasil-9, which protects against nine strains of HPV (as opposed to four). The "Vaccines" section of this article needs to be updated with that information. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm Muzilon (talk) 11:12, 8 March 2015 (UTC)
At least get a picture of the infection or something like that. I really do not want to upload it myself because I am not good with copyright. --Thenewguy34 (talk) 00:20, 1 February 2013 (UTC)
Number of identified subspecies of HPV[edit]
The article states there are 120 types but over in the Plantar wart article it references HPV-156 which implies there are at least 156 identified viruses. What is the actual number currently known and if it is 120 why did the numbering scheme skip up to 156? 184.108.40.206 (talk) 19:08, 17 April 2013 (UTC)
- The HPV and Anal Cancer Foundation, a non-profit organization dedicated to HPV research and support of anal cancer (and other HPV-related cancers) sufferers, states that there are over 200 types of HPV: "There are over 200 HPV strains that can affect the human body. The vast majority of these viruses affect the skin and cause benign warts. About 40 HPV types are sexually transmitted and about 15 of those strains cause lesions that can progress to cancer." There is more information as well. http://www.analcancerfoundation.org/learn/hpv/ Thank you, Wordreader (talk) 17:05, 6 August 2014 (UTC)
"14% to 90% prevalence" is misused quote?[edit]
The article section about genital HPV prevalence says "estimates of HPV prevalence vary from 14% to more than 90%.[154]", but use of this quote seems to be misleading.
The abstract for the linked article (I didn't read the actual study) describes it as surveying many different studies, many (most?) of which are not the "general population". Right after stating the "14% to 90%" results, the abstract says "The highest prevalence of HPV was identified among women attending sexually transmitted diseases (STD) clinics and college students [..] Conversely, the lowest HPV prevalence was among women in the general population." From this it can be assumed that the "90%" figure was e.g. women at STD clinics - certainly not a representative sample for the general population, which is how the quote is being used in the article.
Thoughts on that? It would seem the stat should be replaced with a number reflecting varying estimates of general population prevalence, or changed to something like "depending on the population studied (e.g. the general population or women at STD clinics), HPV prevalence estimates vary from 14% to more than 90%", but I'm not sure such a setence holds a lot of value. — Preceding unsigned comment added by 188.8.131.52 (talk) 19:56, 1 October 2013 (UTC)
- From the HPV and Anal Cancer Foundation site: "According to The American Social Health Association, 80% of sexually active individuals in [sic] will be exposed to HPV in the United States. The National Health Service (NHS) estimates that 80% of sexually active individuals will be exposed to HPV in the United Kingdom." That's not exactly what you asked, but with more searching, you may find it.
- http://www.analcancerfoundation.org/learn/hpv/
- Thank you, Wordreader (talk) 01:57, 28 September 2014 (UTC)
Request Updates to Diagnosis: Cervical testing[edit]
|An edit request by an editor with a conflict of interest has now been answered.
Under Diagnosis, Cervical testing, replace the "quoted" information below:
According to the National Cancer Institute, "testing samples of cervical cells is an effective way to identify high-risk types of HPV that may be present. The FDA has approved an HPV test as a follow-up for women who have an ambiguous Pap test and, for women over the age of 30, for general cervical cancer screening. This HPV test can identify at least 13 of the high-risk types of HPV associated with the development of cervical cancer. The test can detect high-risk types of HPV even before there are any conclusive visible changes to the cervical cells."
According to the National Cancer Institute, "The most common test detects DNA from several high-risk HPV types, but it cannot identify the type(s) that are present. Another test is specific for DNA from HPV types 16 and 18, the two types that cause most HPV-associated cancers. A third test can detect DNA from several high-risk HPV types and can indicate whether HPV-16 or HPV-18 is present. A fourth test detects RNA from the most common high-risk HPV types. These tests can detect HPV infections before cell abnormalities are evident.
"Theoretically, the HPV DNA and RNA tests could be used to identify HPV infections in cells taken from any part of the body. However, the tests are approved by the FDA for only two indications: for follow-up testing of women who seem to have abnormal Pap test results and for cervical cancer screening in combination with a Pap test among women over age 30."[1]
Reason for Change:
The current page cites information from the National Cancer Institute's (NCI) site in 2010. This information is no longer accessible on the current NCI website. I recommend that we update this section with information from the current National Cancer Institute: HPV and Cervical Cancer page. This information reviews four HPV detection tests and the current FDA indications for such tests.
|An edit request by an editor with a conflict of interest has now been answered.
Under Diagnosis, Cervical testing, add:
In April 2011, the Food and Drug Administration approved the cobas HPV Test, manufactured by Roche.[2] This cervical cancer screening test "specifically identifies types HPV 16 and HPV 18 while concurrently detecting the rest of the high risk types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68)."[3]
The cobas HPV Test was evaluated in the ATHENA trial, which studied more than 47,000 U.S. women 21 years old and older undergoing routine cervical cancer screening. [4] Results from the ATHENA trial demonstrated that 1 in 10 women, age 30 and older, who tested positive for HPV 16 and/or 18, actually had cervical pre-cancer even though they showed normal results with the Pap test. [5]
Reason for Change:
The section discusses FDA-approved HPV tests but does not have a full listing of FDA-approved HPV tests. The FDA approved the cobas HPV Test in 2011 to detect high-risk HPV types. We recommend adding an explanation of the test and supporting clinical trial information. References provided for this addition are WP:NPOV. They include a FDA page and a study published in American Society for Clinical Pathology.
— Preceding unsigned comment added by 184.108.40.206 (talk • contribs) 18:30, 9 October 2013
- Note Both requested edits appear to have been implemented by 220.127.116.11 (talk · contribs) two weeks later. Voceditenore (talk) 17:44, 3 March 2014 (UTC)
- ^ "National Cancer Institute Fact Sheet: HPV and Cancer". Cancer.gov. Retrieved 9 October 2013.
- ^ "FDA Approval of cobas HPV Test – P1000020". U.S Food and Drug Administration. Retrieved 9 October 2013.
- ^ "FDA Approval of cobas HPV Test – P1000020". U.S Food and Drug Administration. Retrieved 9 October 2013.
- ^ Wright TC Jr, Stoler MH, Sharma A; et al. (2011). "Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results". Am J Clin Pathol. 136 (4): 578–586.
- ^ Wright TC Jr, Stoler MH, Sharma A; et al. (2011). "Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results". Am J Clin Pathol. 136 (4): 578–586.
neoplasia effects[edit]
whether these neoplasia structures will effect the human life — Preceding unsigned comment added by 18.104.22.168 (talk) 04:34, 16 February 2014 (UTC)
Known HPV Genome[edit]
The more I look at the HPV page and the Cervical cancer I notice differences in the data. From Cervical cancer: Of the 150-200 types of HPV known, 15 are classified as high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82), 3 as probable high-risk (26, 53, and 66), and 12 as low-risk (6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and CP6108). Before my change on HPV: Of the 120 known human papillomaviruses, 51 species and three subtypes infect the genital mucosa. Of these 31 are considered to present a low risk of carcinogensis; 17 are considered to be high risk and 6 are of intermediate risk. I would like to know if anyone could clarify the differences with some modern sources? I know think that my change can be undone but it should be replaced with something consitent between the two pages. Also, does anyone know if I should be posting on both talk pages? Another example: Cervical cancer: Human papillomavirus type 16 and 18 are the cause of 75% of cervical cancer globally while 31 and 45 are the cause of another 10%. HPV Article: High-risk oncogenic HPV types (including HPV 16 and HPV 18) are associated with 99.7% of all cervical cancers. While the two don't conflict, I think that it would be nice to either include both for prospective or to come up some other information, what do others think?Hardkhora (talk) 21:34, 18 March 2014 (UTC)
please check my reversion[edit]
I got a notice today that someone added "There is currently black salve zinc chloride treatment for HPV infection.(1)(135)(136)" under the Treatment section. Of course, none of "citations" used say any such thing. I undid the spam/vandalism, but it's the first time I have ever done this. Can someone more knowledge please check that I did it correctly? Thank you for your time, Wordreader (talk) 23:44, 9 August 2014 (UTC)
ADDENDUM: I'm sorry, but I can't get rid of those unwanted references at the bottom of this post. Please ignore them. Wordreader (talk) 23:49, 9 August 2014 (UTC)
Vaccines, Paragraph 2, removed unattested statement[edit]
In the 'Vaccines' section, paragraph 2, sentence 1, the sentence read, "The vaccines provide little benefit to women having already been infected with HPV types 16 and 18, which includes most sexually active females." I was surprised to see the assertion, since it would obviously mean that a huge portion of the population is at risk, so I checked it. I read through the entire text that the footnote pointed to. There was no mention anywhere that types 16 and 18 'includes most sexually active females', so I removed the clause.Star-lists (talk) 00:18, 23 October 2014 (UTC)
Reference #56 slightly derailed.[edit]
For this reference number, the citation is as follows:
Tay SK, Ho TH, Lim-Tan SK (Aug 1990). "Is genital human papillomavirus infection always sexually transmitted?" (Free full text). The Australian & New Zealand journal of obstetrics & gynaecology 30 (3): 240–242. doi:10.1111/j.1479-828X.1990.tb03223.x. ISSN 0004-8666. PMID 2256864.
The ISSN links to the correct journal as listed in WorldCat, the doi links to the correct article on the Wiley Online Library, but the article title links to a Medline Plus webpage titled "Genital Warts. Sorry, but I'm lost when it comes to manipulating citations. Thank you, Wordreader (talk) 08:35, 19 November 2014 (UTC)
ADDENDUM: I either made an error or the article is no longer available in a full free format, but as a first page peek only: http://onlinelibrary.wiley.com/doi/10.1111/j.1479-828X.1990.tb03223.x/pdf Oops, Wordreader (talk) 19:49, 7 December 2014 (UTC)
- Greetings:
- The error still exists in reference #56. The linked title still goes to that Medline page on genital warts instead of the "Is genital human papillomavirus infection always sexually transmitted?" journal article. Can someone who knows how to wrangle citations please repair that erroneous link? It should go to the preview peek page at: http://onlinelibrary.wiley.com/doi/10.1111/j.1479-828X.1990.tb03223.x/pdf Thank you, Wordreader (talk) 19:49, 7 December 2014 (UTC)
would anyone be willing to take a look at my editing?[edit]
Would anyone be willing to take a look at my edits and give me their opinion?Whereismylunch (talk) 06:11, 7 December 2014 (UTC) How do I remove these links from my thread?Whereismylunch (talk) 18:06, 8 December 2014 (UTC)
Cancer section - unclear sentence[edit]
"Furthermore, HPV can induce a tumorigenic process by integration in host genome associated with alterations in DNA copy number, no funcional [sic] alternative splicing, inter and intrachromosomal rearrangements and changes in patterns of DNA methylation, the latter also produced by the virus extracrhomosomal."
- OK, can someone please translate this newly-added sentence into plain English? Muzilon (talk) 12:00, 15 March 2015 (UTC)
- You are referring to content in the 3rd paragraph (needed so the whole section does not have to be read). Being a medical and scientific journal this does not need explaining. WAIT! Wikipedia is NOT a scientific and/or medical journal? OMG! Tumorigenic means capable of forming or tending to form tumors. There is a "further explanation needed" tag but that should be "translation needed". Other than that I have no idea what is meant and I suspect you may find it hard to locate an interpreter.
- The sentence begins with "Futhermore" (additionally) and then goes into language, that means zero to the average reader, so there is no actual way to tie the content to what is previously stated.
- The last sentence In the United States, HPV is expected to replace tobacco as the main causative agent for oral cancer gives a reference to the "California Dental Hygienists' Association" (http://cdha.org/) that does not present ANY information to support the sentence without possibly reading the entire website and links.
- The article needs to be reviewed for a possible rewrite. At the very least sections need to be updated and checked for cohesion and readability. What does no funcional alternative splicing mean being thrown into the sentence? Was it just copied from text? The spelling "funcional" I suspect is meant to be functional but what do I know. The content is supported by a reference, here, that (in a box marked "significant") states: "However, the role of HPV integration in primary tumors beyond increasing the expression of viral oncoproteins is not understood.", and does not support content. I question the entire content, general inclusion as being possible OR or POV, with the purely medically (scientifically) presented wording that is confusing at best.
- The jest of the paragraph is that HPV is associated with cancer, especially oral cancer, but everything from "Furthermore" to the end does not help and is not directly supported by a source.
Outdated lead and sections[edit]
- I placed an outdated tag in the lead because there is information in the 4th paragraph (...but even so there were 11,000 cases and 3,900 deaths in the U.S. in 2008.) that surely can be updated as this is 2015.
- Information in the body has dates from 2002 (Cancer section), 2005 and 2009 (Blood section), and 2008, but does have some from 2010 (2010 International Papillomavirus Conference). I feel that there has to be some updated information later than 2002. There was a conference in 2015, the 30th conference (www.hpv2015.org), so hopefully someone will look at this.
- Articles like this are important to men, women, and Wikipedia. The projects associated with them have tagged them as High-importance and Top-importance. With this in mind the article needs to be reviewed for updated information. Please do not remove this tag without addressing the issue. Otr500 (talk) 13:23, 24 March 2015 (UTC)
Looks like tag-bombing[edit]
...but it really isn't. I have the references to update this article and I am marking the statements that require the referencing that I will do
- Bfpage |leave a message 01:40, 9 July 2015 (UTC)
What the ... ?[edit]
- An estimated 561,200 new cancer cases worldwide (5.2% of all new cancers)
- 84% of new cervical cancers
- 50% of all new cancers
- 99.7% of all cervical cancers
This whole paragraph could be claiming either "types of cancers" or "cancer cases".
I have also added some clarify tags, as there are several sentences that make little sense, and could even be said to be misleading.
"might benefit some sub-populations of men or women engaging in anal sex"
Aside from the 'or' being incorrect as it should be 'and' as both men and women that engage in it are at risk, unless the testing will only help men or women, which would be ridiculous for them not to know.
They already know it works in men - how do I know? It's in the bl**dy ref!
"Two HIV-positive gay men—Matt Sharp, from Chicago, and Mark Milano, from New York City—have braved anal cancer scares in the last year. Both caught their cancer at an early stage, largely because they'd been screened with anal Pap smears years ago, found to have precancerous lesions, and have been monitored closely ever since."
After reading a quarter of the article, it is in terrible shape. Chaosdruid (talk) 13:39, 24 September 2015 (UTC)
I have successfully and fairly easily removed three warts on my own genitalia using 80% acetic acid (found in groceries) with a Q-Tip to the area, holding it for 40 seconds and afterward rinsing with water. After a day the warts turned white and the application zone - typical of chemical burn. After two weeks the wound was cured and all of them gone. It cost me 1$. 18.104.22.168 (talk) 23:30, 29 December 2015 (UTC)
Error in the HPV article[edit]
Under the Epidemiology section of the article, a reference is made to the American Social Health Association, but the citation links to the American Sexual Health Association for the statistic that 75-80% of sexually active Americans will be infected with HPV at least once in their lifetime. Also, the links in the references are no longer valid for both citations on that statistic but I quickly found a link that was. http://www.ashasexualhealth.org/podcast-hpv-ina-park-md/ 184.108.40.206 (talk) 21:08, 23 July 2016 (UTC) July 23 2016
- You are absolutely correct. I've started to work on improving these outdated refs. Thank you. See your talk page for more information. Best Regards,
- Barbara (WVS) (talk) 21:28, 23 July 2016 (UTC)
Major edit for clarity[edit]
I just did a fairly major reorganization of the lead and first few sections of this article. My goal was to improve clarity and eliminate redundancy. In particular, the previous edit of the page often produced redundant information by repeating the same or similar assertions under different headings. In some cases the article made contradictory assertions in different places (e.g. the percentage of cervical cancers caused by HPV types 16 and 18). I think these problems were the result of growith of the article by piecemeal addition rather than holistic modification.
To resolve these problems, I grouped together information by topic, separating the different symptoms and also the different associated cancers.
- Wwallacee (talk) 13:43, 11 August 2016 (UTC)
With respect to "The precancerous lesions increase the risk of cancer of the cervix, vulva, vagina, penis, anus, mouth, or throat.[1][2] Nearly all cervical cancer is due to HPV with two types, HPV16 and HPV18, accounting for 70% of cases.[1][3] Between 60 to 90% of the other cancers are also linked to HPV.[3]"
We first list all the cancers that HPV increases the risk of. Next sentence we common on the most common cervical cancer Than in the third sentence we touch on all the other cancers mentioned in sentence number on Doc James (talk · contribs · email) 18:54, 11 August 2016 (UTC)
- In response to the above comments:
- 1. Thank you all for mostly respecting my edit in the final analysis, in spite of some citation problems which may have been introduced inadvertently.
- 2. The redundancy I called attention to was not in the lead, but in the subsequent sections, and often involved contradictions between facts asserted in the different sections. Again, I am not going to go through the piece with a fine-tooth comb to prove this, but if you look at the percentages of cases of cervical cancer alleged to be caused by HPV types 16 and 18, you will see what I'm talking about.
- 3. The problems with clarity that I called attention to had to do with conflation of various types of HPV and various associated clinical symptoms. An example of this has been reintroduced into the lead, so I will quote it to demonstrate the point: "It is cause [sic] by a human papillomavirus, a DNA virus from the papillomavirus family. Risk factors for persistent HPV infections include early age of first sexual intercourse, multiple partners, smoking, and poor immune function. HPV is typically spread by sustained direct skin-to-skin contact with vaginal and anal sex being the most common method]"
- In the above quote, note the conflation of HPV per se with sexually transmitted HPV, which is only one subtype. Note also the grammatical error, indicative of a prior edit by a person with poor command of English, which has now been reintroduced.
- Best wishes, - Wwallacee (talk) 09:08, 12 August 2016 (UTC)
- 2. The lead is supposed to summarize the body. Agree that the lead is sometimes update and corrected when the body is not.
- 3.a. This is correct and refers to the disease generally not a specific type "It is cause [sic] by a human papillomavirus, a DNA virus from the papillomavirus family."
- b. Each of these risk factors is true for some type including some for none sexually transmitted types "Risk factors for persistent HPV infections include early age of first sexual intercourse, multiple partners, smoking, and poor immune function."
- c. This is true for the disease generally "HPV is typically spread by sustained direct skin-to-skin contact with vaginal and anal sex being the most common method" and then highlights the most specific notable route.
- Yes I am the person with a poor command of English grammar which I would argue is not the same as poor command of English. I have added a "d" to "cause" Doc James (talk · contribs · email) 16:18, 12 August 2016 (UTC)
- Best wishes, - Wwallacee (talk) 09:08, 12 August 2016 (UTC)
- ^ a b "Human papillomavirus (HPV) and cervical cancer". WHO. June 2016. Retrieved 10 August 2016.
- ^ Ljubojevic, Suzana; Skerlev, Mihael (2014). "HPV-associated diseases". Clinics in Dermatology. 32 (2): 227–234. doi:10.1016/j.clindermatol.2013.08.007. ISSN 0738-081X. PMID 24559558.
- ^ a b "The Link Between HPV and Cancer". CDC. September 30, 2015. Retrieved 11 August 2016.
- B-Class medicine articles
- High-importance medicine articles
- B-Class reproductive medicine articles
- High-importance reproductive medicine articles
- Reproductive medicine task force articles
- All WikiProject Medicine articles
- B-Class Women's health articles
- High-importance Women's health articles
- WikiProject Women's health articles
- B-Class virus articles
- Top-importance virus articles
- WikiProject Viruses articles
- C-Class Version 1.0 articles
- Unknown-importance Version 1.0 articles
- Natural sciences Version 1.0 articles
- Unknown-importance articles
- Wikipedia Version 0.7 selected articles
- Natural sciences Version 0.7 articles
- Wikipedia Version 1.0 articles
- Wikipedia requested images of medical subjects
- Implemented requested edits


text:
The lives of 2 million UK citizens living, working and travelling in the other 27 Member States would be affected if Britain was to leave the EU, according to an official government's paper.
Britons living on the continent may lose a range of specific rights that are only guaranteed because of EU law. These include the rights to live and work but also access to pensions, health care and public service, the Cabinet office warned in his first official report into the impact of a future Brexit.
"There would be no requirement under EU law for these rights to be maintained if the UK left the EU. Should an agreement be reached to maintain these rights, the expectation must be that this would have to be reciprocated for EU citizens in the UK," the report said.
It could take Britain up to ten years to negotiate new trade deals with Europe, government officials warned.
David Lidington, Europe minister, said that the British exit could also prevent UK citizens from moving abroad.
"Everything we take for granted about access to the single market – trade taking place without customs checks or paperwork at national frontiers, the right of British citizens to go and live in Spain or France – those would all be up in the air. It is massive. It is massive what is at risk," he said in an interview with the Observer.
Spain has the biggest British expat community in Europe with more than 380,000 people, followed by Republic of Ireland with around 250,000 and France with more than 172,000, according to United Nations statistics.
The study says the doubt will negatively impact on "financial markets, investment and the value of the pound" and lead to a "decade of uncertainty".
George Peretz QC, an expert on EU law said UK citizens might lose much more than their rights to French state health services.
"UK citizens would lose their EU law rights to work, to set up a business, to buy property, to bring family to live with them, not to be deported for trivial offences and so on. France might let them do all those things. But that would be entirely up to France," told The Local France.
The Prime Minister said the only way to leave the EU, if British people were to vote in favour of Brexit on June 23, would be to trigger Article 50 and begin the process of withdrawal.
The process is unprecedented, as no other country has ever used it before.
What's the European Parliament ever done for us?
What's the European Parliament ever done for us?
1/5 A cap on the amount of hours an employer can make you work
The Working Time directive provides legal standards to ensure the health and safety of employees in Europe. Among the many rules are a working week of a maximum 48 hours, including overtime, a daily rest period of 11 hours in every 24, a break if a person works for six hours or more, and one day off in every seven. It also includes provisions for paid annual leave of at least four weeks every year
Getty Images
2/5 Helping the people of Britain to avoid smoking
In 2014 MEPs passed the Tobacco Products Directive strengthening existing rules on the manufacture, production and presentation of tobacco products. This includes things like reduced branding, restrictions on products containing flavoured tobacco, health warnings on cigarette packets and provisions for e-cigarettes to ensure they are safe
3/5 Helping you to make the right choices with your food
Thanks to the European Parliament, UK consumers have access to more information than ever about their food and drink. This includes amount of fat, and how much of it is saturated, carbohydrates, sugars, protein and so on. It also includes portion sizes and guideline daily amount information so people can make informed choices about their diet. All facts must be clear and easy to understand
4/5 Two year guarantees and 14-day returns policy for all products
Consumers across the EU have access to a number of rights, from things which are potentially very useful, to things which used to be annoying. For example, shoppers in the UK receive a two-year guarantee on all products, and a 14-day period to change their minds and return a purchase, these things are useful
www.PeopleImages.com-licence restrictions apply
5/5 Keeping your air nice and fresh (and safe)
Believe it or not, although the situation is improving, some areas of the UK have appalling air quality. A report by the Royal College of Physicians released on 23 February says 40,000 deaths are caused by outdoor air pollution in the UK every year. Air pollution is linked to a number of illnesses and conditions, from Asthma to diabetes and dementia. The report estimates the costs to British business and the health service add up to £20 billion every year
"A vote to leave the EU would be the start, not the end, of a process. It would begin a period of uncertainty, of unknown length, and an unpredictable outcome. The broad procedural route is set out in Article 50 of the Treaty on European Union, ensuring exit is possible. But beyond procedure, nothing is agreed and nothing has been tested," the report said
"It is important the risk this [Brexit] present is understood," it concluded.
However Boris Johnson, who has announced his support for the "out" campaign, has accused the Prime Minister and other campaigner of scaring voters.
"It is now obvious that the Remain campaign is intended to provoke only one emotion in the breast of the British public and that is fear," he said in his column in the Daily Telegraph.
- More about:
- Brexit
- European Union
- EU referendum
- British expats

subset: commoncrawl


text:
Dewhurst Attacks Obama on Health Reform in New Ad
In a new video ad, Lt. Gov. David Dewhurst, who is in a four-way primary race to keep his seat, attacks President Obama and his signature health care law, saying, "I can't think of one thing I agree with him on."
Texas Tribune donors or members may be quoted or mentioned in our stories, or may be the subject of them. For a complete list of contributors, click here.
Hide all comments Show 71 comments


text:
The fightback starts today.
It's no secret that Cybersecurity is fast becoming one of the biggest trends that we all need to be on top of.
With incidents happening almost every day, big business and governments are both taking the issue more seriously than ever. Naturally the jobs market has reacted with figures released today by Procorre revealing 14% of all British tech vacancies are for cybersecurity roles.
Demand is high and salaries are rising, the report also showed that 15% of these new roles now command of pay packets of over £100,00.
Like many fast growing areas in the UK, there is an acute lack of talent to fill the gap. The Government is keenly aware of this and recently backed the launch of CyLon, Europe's first cybersecurity business accelerator.
Run by the already successful Ignite Accelerator, the programme will see businesses work closely with government agencies to help the fightback against cybercrime.
Universities have also stepped in. Oxford, Warwick, University College London, and Royal Hollway all now offer degrees in various forms of Information Security.
After a series of high-profile breaches, data security has gone from niche topic to the top of many corporate agendas.
Half of US firms have responded with increased cybersecurity budgets in the past two years. This comes after numerous breaches including extra-marital affairs site Ashley Madison, which saw the details of millions of users leaked.
Further analysis of Ashley Madison's data made for tough reading as The Memo revealed last month up to 95% of the site's users were men and 130 British government emails were used to sign up.
Aside from the public humiliation, cybersecurity can hit the bottom line as companies could be at risk of fines up to 5% of global revenue following debates in the European Parliament.
Commenting on the jobs report, Wiktor Podgorski, Contracts & HR Manager at Procorre, said:
"With the new directive imminent, businesses need to be even more secure with the data they are storing. Cyber security experts are being drafted in to address any concerns that could see hackers access sensitive information, which may lead to a drop in revenue and a hefty fine. Not to mention the reputational damage."
Curated by The Memo's editorial team, The Daily Memo is the essential digest of innovative ideas for forward thinking people.


text:
Fri, 07/09/2012 - 10:17
The Dow Jones Credit Suisse Core Hedge Fund Index closed up 0.56 per cent in August as five of the seven index component strategies reported positive results.
Fri, 07/09/2012 - 06:05
Hedge fund managers tracked by the AlphaClone Hedge Fund Long/Short Index distanced themselves from financial sector investments in the second quarter, representing a steep reversal from the previous quarter in which financials were the index's most overweight sector relative to the S&P 500.
Fri, 07/09/2012 - 06:00
Hedge funds are continuing to develop risk management practices that fit the needs of investors and fund managers alike, according to a study from the Managed Funds Association, BNY Mellon, and HedgeMark.
Thu, 06/09/2012 - 15:58
Envestnet, a provider of technology-enabled wealth management solutions for investment advisers, has formed a hedge fund research alliance with Fund Evaluation Group (FEG), an institutional investment consulting firm.
Thu, 06/09/2012 - 14:36
The Credit Suisse Liquid Alternative Beta Index was up 0.53 per cent in August, according to Jordan Drachman, head of research for alternative beta strategies at Credit Suisse.
Thu, 06/09/2012 - 14:07
The lines between institutional asset managers and alternative investors are becoming increasingly blurred due to investment strategies, priorities and goals becoming aligned, according to Martin Boyd, president of SunGard's asset management business.
Thu, 06/09/2012 - 12:07
The Securities and Exchange Commission has charged an attorney and two others living in South Florida for their roles in a USD27.5m investment scheme that led investors to believe they were purchasing securities consisting of "pre-sold" commodities contracts with a pre-determined profit.
Thu, 06/09/2012 - 10:34
Newedge has made two appointments in its alternative investment solutions (AIS) group, a part of Newedge's prime clearing services.
Thu, 06/09/2012 - 06:31
Alternative investment company Aquila Capital's AC Risk Parity 12 Fund has achieved four years of consistently positive year-on-year returns.
Thu, 06/09/2012 - 06:20
The Securities and Exchange Commission has charged a California man with illegally tipping a hedge fund manager with inside information about Nvidia Corporation's quarterly earnings that he learned from his friend who worked at the company.
Copyright © 2017 GFM Ltd. All Rights Reserved


text:
Kenneth Johnson (producer)
|This biography of a living person needs additional citations for verification. (August 2013) (Learn how and when to remove this template message)
|Kenneth Johnson
October 26, 1942
Pine Bluff, Arkansas, United States
|Television producer, director, screenwriter
|Years active
Kenneth Culver Johnson (born October 26, 1942) is an American screenwriter, producer and director. He is known as the creator of the V science fiction franchise as well as The Bionic Woman (1976–78), The Incredible Hulk series (1977–82), and the TV adaptation (1989) of Alien Nation. His creative efforts are almost entirely concentrated in the area of television science fiction.
A native of Pine Bluff, Arkansas, Johnson is a graduate of the Carnegie Institute of Technology.[1]
His early TV work includes The Six Million Dollar Man, The Bionic Woman and The Incredible Hulk. Johnson created the character of Jaime Sommers and the The Bionic Woman, an American television series starring Lindsay Wagner that aired for three seasons between 1976 and 1978 as a spin-off from The Six Million Dollar Man.[1]
In 1983, he wrote and directed the original miniseries V, about an invasion of Earth by reptilian aliens, originally inspired by Sinclair Lewis' anti-fascist novel It Can't Happen Here (1935).[1] The miniseries aired on NBC, and a year later was followed by a sequel, V: The Final Battle, which Johnson briefly worked on before leaving the project due to disagreements with the network. Johnson was subsequently credited as a co-writer of the sequel miniseries under the pseudonym Lillian Weezer, and was not involved at all in the weekly V television series that followed.
In 1989, he produced the television series Alien Nation based on the 1988 film of the same name.
In 1997, he wrote and directed the movie Steel, based on the DC comic book character Steel. It featured basketball player Shaquille O'Neal as John Henry Irons, the character's alter-ego. (Note: This movie is not to be confused with the Lee Majors 1979 movie Steel, filmed in Canada.)
In 2006, Johnson announced his completion of a four-hour script for a new V mini series called V: The Second Generation. The storyline takes place 20 years after the original 1983 mini-series, ignoring the second mini-series (V: The Final Battle) and subsequent weekly television series. However, NBC told Johnson that they were more interested in a remake of the original V mini-series instead, which, if successful, might lead to his proposed sequel.
Since then, Johnson adapted his screenplay for V: The Second Generation into a novel. It was published by Tor Books and released on February 5, 2008. However, since his discussions with NBC, Warner Bros (who hold the television rights to the V franchise) have opted to produce a remake of V (written by Scott Peters) for the ABC Network, thus ending any prospect of Johnson's sequel being produced for television.
In April 2008, Johnson stated his intention to remake the original V mini-series and his new sequel V: The Second Generation into feature films. Johnson claimed to have been in discussions with producers interested in the project. Since this statement, Johnson's potential film production has not been developed further, although talks with potential backers are still ongoing. The Warner Bros. television remake for ABC premiered on November 3, 2009. It was canceled in 2011, after two seasons, due to low ratings.
Personal life[edit]
Johnson married Bonnie Hollaway on February 2, 1963, and they divorced in 1975. They have three children. On June 19, 1977 (the day after completing filming of the pilot movie of The Incredible Hulk series), he married Susan Appling, and they have one child.[1]
- ^ a b c d Gwendolyn Shelton (January 16, 2017). "Kenneth Culver (Kenny) Johnson (1942–)". Encyclopedia of Arkansas. Retrieved November 15, 2011.
External links[edit]
- 21st-century American novelists
- 1942 births
- American film directors
- American film producers
- American male novelists
- American science fiction writers
- American male screenwriters
- American television directors
- American television producers
- American television writers
- Living people
- People from Pine Bluff, Arkansas
- Male television writers